Year : 2019 | Volume
: 149 | Issue : 3 | Page : 396--403
Seroprevalence of measles, mumps & rubella antibodies among 5-10 years old children in north India
Madhu Gupta1, Jaya Prasad Tripathy1, Madhur Verma1, Mini P Singh2, Ramanpreet Kaur2, RK Ratho2, Rajesh Kumar1
1 Department of Community Medicine and School of Public Health, Postgraduate Institute of Medical Education & Research, Chandigarh, India
2 Department of Virology, Postgraduate Institute of Medical Education & Research, Chandigarh, India
Background & objectives: Globally, there is an effort to eliminate the measles and control rubella as these diseases lead to considerable morbidity and mortality especially among under-five children and are important public health problems. This study was aimed to estimate the seroprevalence of measles, mumps and rubella (MMR) antibodies among children of age 5-10 yr in Chandigarh, north India, to provide evidence on prevalent immunity levels.
Methods: This cross-sectional study was conducted in Chandigarh, among 196 randomly selected healthy children (5-10 yr), who received either one or two doses of measles or MMR combination vaccine. Socio-economic background and immunization history were recorded. Blood sample (2 ml) was collected to estimate the MMR IgG antibody titres by using ELISA kits.
Results: Protective seroprevalence of MMR antibodies was 40.8, 75.5 and 86.2 per cent, respectively. The geometric mean titres of MMR IgG antibodies in the study children were 11.3, 50.6 and 54.3 international units (IU)/ ml, respectively. The proportion of seroprotected children for measles was significantly higher among those who had received two or more doses (46.4%) of measles vaccine compared to those who had received single dose (35.6%) (
P <0.001). About 16 per cent of children had received single dose of MMR vaccine. Among these, 71.4 and 100 per cent were seroprotected against mumps and rubella, respectively.
Interpretation & conclusions: A large proportion of children aged 5-10 yr lacked protective immunity against measles (60%); about one-fourth (15-25%) were susceptible to infection with mumps and rubella virus. Mumps vaccination may be considered to be included in National Immunization Schedule for children with periodic serosurveillance.
Dr Madhu Gupta
Professor, Department of Community Medicine and School of Public Health, Postgraduate Institute of Medical Education & Research, Sector 12, Chandigarh 160 012
|How to cite this article:|
Gupta M, Tripathy JP, Verma M, Singh MP, Kaur R, Ratho R K, Kumar R. Seroprevalence of measles, mumps & rubella antibodies among 5-10 years old children in north India.Indian J Med Res 2019;149:396-403
|How to cite this URL:|
Gupta M, Tripathy JP, Verma M, Singh MP, Kaur R, Ratho R K, Kumar R. Seroprevalence of measles, mumps & rubella antibodies among 5-10 years old children in north India. Indian J Med Res [serial online] 2019 [cited 2021 Feb 27 ];149:396-403
Available from: https://www.ijmr.org.in/article.asp?issn=0971-5916;year=2019;volume=149;issue=3;spage=396;epage=403;aulast=Gupta;type=0